Quincy Bioscience LLC
This article was originally published in Start Up
Insights into calcium's role in neurodegeneration is encouraging research into the role it plays in Alzheimer's and other diseases, and in the aging process in general. Much of the work has revolved around the concept of blocking calcium channels, but Quincy Bioscience thinks it has a better approach. Its compound has been utilized in laboratories for 40-some years, but not as a potential drug. It's aeqorin, a luminescent protein originally isolated from jellyfish.
You may also be interested in...
Outsourcing is not just for mundane pharma services anymore. Increasingly, drugmakers are contracting for specialized R&D assistance they expect to provide strategic as well as tactical advantages.
Like other companies investigating entirely new ways of treating bacterial infections, biotech start-up Spero is increasingly aware that novel antibiotics may need to travel new clinical and regulatory pathways to market.
RxMP Therapeutics LLC is working to resolve excessive diffuse bleeding that is often associated with trauma, and also with certain orthopedic and cardiovascular surgeries. The start-up believes it can successfully treat excessive diffuse bleeding with particles produced from the membranes of red blood cells that have been freeze-dried and then, literally, blown to bits.